FDA Import Refusal AEK-0274363-0/10002/1 — ELI LILLY CANADA INC
The FDA refused shipment AEK-0274363-0/10002/1 from ELI LILLY CANADA INC (Canada) on Apr 22, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 22, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75